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Molecular characteristics 
of MRSA strains and patient 
risk factors in vascular 
surgery
ABSTRACT
Methicillin-resistant Staphylococcus aureus (MRSA) is one of the major pathogens in hospitals, and since the 1990s it has 
been recognized as an important pathogen in community infections. (1) The aim of this study was to analyze MRSA strains 
from a vascular surgery ward over a five-year period, since the vascular ward is considered to be a high-risk site for different 
multi-resistant pathogens, among which MRSA is very important. The method used for the microbiological identification 
and susceptibility testing of strains was the Vitek2 system. For the detailed characterization of the MRSA strains, we used 
the following molecular methods: SCCmec typing, pulse-field gel electrophoresis (PFGE), spa typing and Panton-Valentine 
leukocidin (PVL) detection. During the 5-year period, 77 MRSA strains were isolated. Antimicrobial susceptibility: 100% of 
MRSA isolates were susceptible to oxazolidinones and glycopeptides, 55% were susceptible to gentamycin, and 98% were 
susceptible to tetracyclines.  SCCmec typing: 43 of 77 (55.8%) strains were typed as SCCmec I. The number of isolates 
with SCCmec II was 28 (36.4%). Three isolates carried SCCmec III.
After the PFGE analysis, the isolates were grouped into six similarity groups: A-F. The largest number of isolates (80.6%) 
belonged to one of two groups: A: 35 (46.8%) and D: 25 (33.8%). Conclusion: The analysis of MRSA strains in the vascular 
surgery ward revealed high homogeneity among the strains, the majority of which belonged to SCCmec type I. This type, 
together with the susceptibility profile and PFGE grouping, is considered to be typical of Hospital-Acquired (HA) MRSA.
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Introduction
Staphylococcus aureus (S. aureus) can 
cause a wide range of human infections, 
including boils, furuncles, pneumonia, 
meningitis, sepsis, and postoperative 
surgical site infections (SSIs). (1,2)  A 
resistant variant, methicillin-resistant 
Staphylococcus aureus (MRSA), can 
cause the same range of infections, 
and infections that are not treated in a 
timely manner can cause more severe 
consequences than infections that are 
properly treated. The common ana-
tomic locations of MRSA carriage are 
the nares, groin, throat, and any woun-
ds that are present, as for S. aureus. 
(3) The reduction of patient-to-patient 
MRSA transmission is an important 
aspect of the prevention of healthcare-
associated MRSA infection. (4) Methi-
cillin was first introduced in 1959, and 
the first Staphylococcus aureus isolates 
that are resistant to methicillin appea-
red in 1961 in the UK. (5) MRSA is one 
of the major pathogens in hospitals, 
and in the 1990s it was recognized as 
one of the most important pathogens 
in community infections. Several severe 
and fatal cases have been described. 
In the USA, this bacterium causes the 
majority of skin and soft tissue infec-
tions. (6)  In Europe, the burden of 
community-acquired MRSA is much 
smaller, but patients with MRSA colo-
nization or infection are still often found 
in hospitals, (1, 7) One other concern 
is raised by the occurrence of com-
munity strains and the introduction of 
those strains into hospitals. (8, 9)  The 
main difference between HA and CA 
MRSA is in a genetic element called the 
SCCmec cassette, which carries the 
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mecA gene. The mecA gene encodes 
PBP2a, a mutated penicillin-binding 
protein (PBP), which is a marker of 
MRSA and has an active binding site 
for all penicillins and cephalosporins. 
(7) So far, there are 11 known and des-
cribed types of SCCmec and numero-
us subtypes. The first 3, or I, II and III, 
are predominantly found in HA MRSA. 
Others, and especially types IV and V, 
are found in community strains, as are 
many other types (VI-XI). (10)
Because community-associated MRSA 
strains have certain virulence factors, 
such as Pantone-Valentine leukocidin 
(PVL), and the smaller mobile genetic 
element that carries the resistance gene 
mecA, called the SCCmec cassette, 
certain authors consider CA MRSA as 
a substantial threat, especially when 
introduced into hospitals. (1) The aim of 
this study was to analyze MRSA strains 
from one vascular surgery ward over 
a five-year period, since the vascular 
ward is considered to be a high-risk 
site for different pathogens, and espe-
cially MRSA. Vascular SSI occurs as a 
result of preoperative events that lead 
to bacterial colonization of both the 
surgical wound and, frequently, any 
underlying prosthetic graft that may be 
present. (11, 12) The prevention of SSI 
is a major concern for vascular surge-
ons, and reduction of the incidence of 
SSI requires an understanding of the 
changing epidemiological risk factors 
for the development of SSI and the use 
of effective patient care strategies. The 
strategies for the prevention of vascular 
SSI include surveillance, decolonization, 
antibiotic prophylaxis, specific surgical 
techniques, and methods that involve 
the application of impregnated grafts. 
(12) In Croatia, vascular surgery wards 
have historically had endemic MRSA 
strains, since the patients who are often 
hospitalized in these wards are patients 
at high risk of acquiring MRSA – such 
as the elderly, nursing-home patients, 
diabetics and patients with compromi-
sed circulation and tissue oxygenation. 
Due to this shift from HA MRSA to CA 
MRSA, we decided to investigate the 
genetic background and relatedness of 
MRSA in a vascular surgery ward over a 
four-year period and to determine whet-
her our patients were typically carriers 
of or infected with HA or CA MRSA.  If 
the dominant type is still HA MRSA, the 
therapeutic choice is limited to glyco-
peptides, linezolid and daptomycin. 
Figure 1. presents PFGE patterns of the MRSA clones observed in this study
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But if there is a shift toward commu-
nity strains, other therapeutic options 
should be possible. In addition, and 
in such cases, we will need to enhan-
ce our infection control programmes 
because transmission is occurring and 
continuing. Among high-risk patients 
and at admission to high-risk wards, it is 
important to perform screening if such 
screening is part of a hospital policy. 
Moreover, screening results should be 
available as soon as possible. Before 
that, a patient should be placed in a 
single room and treated as possibly 
colonized/infected. Given that there is 
a lack of single-bed hospital rooms, 
and because working hours for labo-
ratories and attending physicians are 
limited, pre-emptive isolation and even 
screening are not routinely performed 
as this approach is costly, and MRSA 
carrier status information is not used 
fully. (12)  One concern in investigations 
of MRSA is the introduction of com-
munity-associated MRSA strains into 
hospitals. Beyond SCCmec typing, the 
characterization of MRSA strains can 
be based on several other techniqu-
es. (13) If the long-term relation and 
origin of the strains are needed, then 
multi-locus sequence typing (MLST) 
is the method of choice. Based on this 
method, the majority of known MRSA 
strains are grouped into 5 major clonal 
complexes, evidencing the high clona-
lity of MRSA strains and also showing 
which lineages were more successful 
than others when the introduction of the 
mecA gene into susceptible S. aureus 
occurred. (14)  For hospital epidemio-
logical purposes, relatedness between 
strains can be established by the use of 
pulse-field gel electrophoresis (PFGE) 
and spa typing. (15-17) 
Materials and methods
MRSA was isolated from patient scree-
ning samples and clinical isolates. The 
screening policy included screening 
on admission and weekly screening 
at three sites: the nose, groin, and axi-
llary area. The swabs were processed 
in a microbiology laboratory using cli-
nical laboratory guidelines and were 
pooled in broth. Colonies with typical 
morphology were identified by stan-
dard microbiological tests (coagulase, 
DNase), and susceptibility testing was 
performed according to EUCAST stan-
dards. (18) MRSA was suspected if the 
cefoxitin zone was 21 mm or smaller. All 
fox-R strains were submitted to molecu-
lar confirmation of mecA, which is the 
gold standard for MRSA confirmation. 
A range of 19 antibiotics was tested for 
each isolate using the Vitek2 system 
and the disk diffusion method accor-
ding to EUCAST.
Molecular analysis of the SCCmec 
cassette was performed using a met-
hod previously described by Oliveria 
et al. (19), with certain modifications 
described by Budimir et al. (20)
PVL was detected using PCR primers 
previously described by Lina et al. (21) 
PFGE was performed as described in 
the study by Tenover et al. with some 
adjustments. (15,16) The band patterns 
were analyzed with Dice comparison 
and unweighted-pair group matching 
analysis settings with GelCompar II 
(Applied Maths, Sint-Martens-Latem, 
Belgium) according to the scheme by 
Tenover et al. (16) MRSA isolates with 
a similarity index of 0.70 or more were 
classified as a clonal group. (22).  A 
relatedness of 80% or more was consi-
dered to be significant, and strains with 
at least 80% similarity were considered 
to be related to each other and were 
grouped together in a similarity group 
or genotype. Spa typing was performed 
according to previously published met-
hods. (23,24) An analysis of sequence 
chromatograms was performed using 
Ridom StaphType™ (Ridom GmbH, 
Wurzburg, Germany).
Figure 1. presents PFGE patterns of the MRSA clones observed in this study
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Results
A total of 77 patients were MRSA posi-
tive at least at one site.  MRSA-positive 
isolates were found more frequently 
in men than in women (75% vs. 25%). 
MRSA was present in 67 wound swabs, 
four throat swabs, two nasal swabs, 
two perineal swabs, one blood culture, 
and one central vascular catheter. In 
total, 41 patients had diabetes, and 
36 did not. Fifty patients were submi-
tted to an operative procedure during 
their stay in the hospital, and 20 were 
not. There were no data on operative 
status for seven patients. Antimicrobial 
susceptibility: 100% of MRSA isolates 
were susceptible to oxazolidinones and 
glycopeptides, 55% were susceptible 
to gentamycin, and 98% were suscepti-
ble to tetracyclines. Additionally, all iso-
lates were resistant to clindamycin and 
erythromycin. SCCmec typing: 43 of 77 
(55.8%) strains were typed as SCCmec 
I. The number of isolates with SCCmec 
II was 28 (36.4%). Three isolates carried 
SCCmec III. Non-typeable strains were 
also found in 3.9% of cases. No isola-
tes with SCCmec IV or V were found 
during this analysis. A summary of the 
results is presented in table 1. After 
the PFGE analysis, the isolates were 
placed together in six similarity groups: 
A-F. The largest number of isolates 
(80.6%) belonged to one of two groups: 
A (35; 46.8%) and D (25; 33.8%). Group 
C included 5.2% isolates, and E and 
F included 3, 9%. Four isolates were 
singletons, i.e., not similar to any of 
the other strains. Placement of strains 
into groups and clonal relatedness are 
shown in picture 1.
Discussion
Comparison grouping by PFGE and 
SCCmec typing was used to determine 
whether our strains belonged to HA 
or CA MRSA strains. The majority of 
isolates in PFGE group D had SCCmec 
type I, and fewer had SCCmec types II 
and III. According to our results, MRSA 
represents a significant causative agent 
of infections and patient colonization in 
a vascular surgery ward at the Universi-
ty Hospital Centre in Zagreb. This ward 
includes predominantly male patients, 
and they are often carriers of, or infec-
ted by, MRSA. (25) Certain diseases 
and conditions are also more often 
found in men, so they are found to have 
MRSA more often than women. Most of 
the patients were over 60 years of age, 
and men with MRSA were significantly 
younger than the female MRSA carriers. 
The risk factors for MRSA colonization/
infection are previous MRSA coloniza-
tion, previous hospitalization, chronic 
diseases, living in a care home, and 
previous antibiotic use. (9) In our pati-
ent group, only 10% of the patients were 
nursing-home residents, but more than 
70% of patients had received antimicro-
bials in the year preceding the current 
hospitalization. It is well known from 
available literature that MRSA emer-
gence is greatly promoted by the use of 
fluoroquinolones and cephalosporins. 
In our patient population, the majority 
of patients were receiving ciprofloxacin. 
It is important to note that there is no 
uniform policy for patient screening in 
the vascular surgery ward, so the majo-
rity of samples were clinically indicated 
samples, in the form of wound swabs. 
(12) Several swabs were obtained from 
chronic wounds, which are often coloni-
zed, especially by gram-negative flora, 
but are rarely infected. We also collec-
ted only one invasive isolate, obtained 
from a blood culture, which is a prefera-
ble sample type because the finding of 
MRSA in blood culture is often a sign of 
bacteremia and may not be treated or 
recognized as severe infection. Becau-
se this single isolate was obtained from 
a single blood culture from a sympto-
matic patient, and given that we did not 
have a properly collected sample, we 
can only assume that this patient was 
septicemic.
Analyzing all other risk factors important 
for vascular insufficiency and MRSA 
carriage/infection, we observed that 
more than half (53%) of the patients 
were diabetic, and the majority were 60 
Table 1. SCCmec types distribution among MRSA isolates in Vascular surgery ward
SCCmec type I SCCmec type II SCCmec type III SCCmec type IV SCCmec type V
Non-typeable
NT
43 (55.8%) 28 (36.4%)
3 (3.9%)
0 0 3 (3.9%)
Table 2. Spa typing results 













years and older, which is typical. These 
findings reflect the additional vulnerabi-
lity of this population and their greater 
probability of infection. Other compro-
mising factors, and often the main rea-
sons for hospitalization, were peripheral 
occlusive illness and hypertension.  In 
examining the susceptibility profiles of 
the tested isolates, we found typical 
HA MRSA profiles: a high percenta-
ge of resistance to gentamycin and 
100% resistance to clindamycin and 
erythromycin. Additionally, all isolates 
were susceptible to glycopeptides and 
linezolid, as well as tigecycline. Results 
from Croatia in the same time period 
were in concordance with our results 
regarding antimicrobial susceptibili-
ty. (26) In efforts to reduce the MRSA 
burden in hospitals and to reduce the 
spread of multiresistant strains, strict 
infection control measures are advised. 
Contact precautions, the isolation of a 
patient in a single room and a decoloni-
zation regimen can be very successful. 
It is useful to apply a screening policy, 
especially in high-risk wards, but it is 
up to the infection control committee 
and microbiology service to choose the 
best method – which should be suita-
ble, rapid and sufficiently inexpensive to 
not burden the hospital budget unduly. 
(4) Because the aim of the current study 
was to try to find community-associated 
MRSA in a vascular surgery ward, we 
used a combination of molecular cha-
racteristics and epidemiological defini-
tions to identify these strains. As far as 
we are aware, there were no CA MRSA 
strains in this population of strains or 
in this population of patients. Because 
patients with this profile are often re-
admitted to the hospital, re-admission 
could represent a risk factor for HA 
MRSA, more so than for CA MRSA. 
SCCmec typing revealed typical HA 
MRSA strains, which was clear even 
after susceptibility testing because the 
susceptibility profiles were typical of HA 
MRSA. The absence of genes encoding 
the toxin PVL also proves that our stra-
ins were CA MRSA.
Spa typing showed 10 spa types, which 
were also not as diverse as one would 
expect. Spa type t041 was most com-
mon in this study, as shown in certain 
previous publications from our coun-
try. This type is typical in Croatia and in 
connection to SCCmec I, which was also 
previously found in certain other Europe-
an countries, such as Germany, Austria, 
the Czech Republic, Sweden and Swit-
zerland, but not on other continents. (5, 
20) Other spa types are also very well 
known in these areas, according to the 
literature and Ridom SpaServer. (3, 5, 
20) Spa type t041 in MRSA, together 
with SCCmec I, is typically presented 
in Southern German MRSA clones. (20) 
The cost and benefit of this type of study 
should be considered in light of the new 
developments in MRSA epidemiology 
and the identification of certain new 
“strange” hypervirulent or community 
strains. The routine use of molecular 
techniques is preferable if a hospital can 
afford it, but traditional microbiological 
methods can also be very effective in 
local epidemiology. The results can be 
(at least preliminarily) communicated 
with wards very soon after the inoculati-
on of strains in selective broth. In Croatia 
in 2005, MRSA represented 19.98% of 
all SA isolates, and the percentage was 
233% in 2008. However, after that year 
the percentage slowly decreased as 
part of a decreasing trend in the global 
MRSA rate.
Conclusion
The molecular characteristics of MRSA 
strains in the vascular surgery ward 
over a 5-year period showed high gene-
tic similarity. Using a combination of 
techniques, we were able to investigate 
the origin and genetic background of 
the strains. PFGE analysis revealed 
two large, genetically related groups of 
strains consisting of 60 isolates.
This finding could have been the result 
of inadequately strict adherence to 
infection control measures, failure to 
apply the screening policy, a lack of 
knowledge about multiresistant strains, 
or the local epidemiological situation, 
which should be the basis of antimi-
crobial empiric therapy for hospitalized 
patients.
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